Goon PKC, Lim HY, Summerfield L, Banfield CC, et al. Real-world experience and analyses of the performance of ixekizumab as first-line biologic agent versus second-line (or higher) biologic agent in the treatment of chronic plaque psoriasis. Int J Dermatol 2021 Apr 4. doi: 10.1111/ijd.15560.
PMID: 33817799